Pharma news
Americas
German pharmaceutical company Boehringer Ingelheim has signed a research collaboration and licence agreement with French and Canadian biopharmaceutical business Domain Therapeutics. 4 December 2018
Americas
GSK has agreed to buy US oncology company Tesaro for $5.1 billion, in a move designed to strengthen its anti-cancer offering. 3 December 2018
Americas
AbbVie has granted Pfizer a non-exclusive global licence to its Humira IP, as announced on Friday, November 30. 3 December 2018
Pharma
Proposed amendments to the EU’s supplementary protection certificate manufacturing waiver risk “further disincentivising investment” in Europe, according to the European Federation of Pharmaceutical Industries and Associations. 30 November 2018
Americas
The University of Wisconsin’s licensing arm has been ordered to pay Washington University $31.6 million in a fight over patent licensing relating to one of AbbVie’s kidney drugs. 30 November 2018
Pharma
The US Food and Drug Administration has granted Pfizer paediatric exclusivity for Lyrica, extending the period of US market exclusivity for the drug by six months. 29 November 2018
Pharma
Japan-based Takeda Pharmaceutical has persuaded the European Union Intellectual Property Office that an applied-for trademark would be confused with its own earlier-registered mark 28 November 2018
Pharma
In November, the UK Supreme Court ruled that Warner-Lambert’s patent for a second medical use of pregabalin for the treatment of pain is invalid for insufficiency of disclosure. Sheena Linehan of Potter Clarkson explores the lessons for patent drafting. 28 November 2018
Asia-Pacific
India-based drug company Sun Pharma has made further inroads into the Japanese market with the planned acquisition of Pola Pharma. 26 November 2018
Pharma
The EU General Court dismissed Canada-based Endoceutics’ trademark appeal in a win for medical technology company Merck KGaA on Thursday, November 22. 26 November 2018